GH1 and cardiomyopathy: Alterations in GH-IGF-I axis observed with changes in LV mass may serve as a sensitive screening tool for earlier detection of cardiac wasting–associated cardiomyopathy in patients with cancer to allow for earlier implementation of appropriate treatment measures.